Luye Pharma Group Ltd. (OTCMKTS:LYPHF – Get Free Report) was the target of a significant drop in short interest during the month of July. As of July 31st, there was short interest totaling 593,731 shares, a drop of 57.3% from the July 15th total of 1,389,331 shares. Based on an average daily trading volume, of 417 shares, the short-interest ratio is presently 1,423.8 days.
Luye Pharma Group Stock Performance
LYPHF stock remained flat at $0.27 during mid-day trading on Friday. Luye Pharma Group has a 1 year low of $0.20 and a 1 year high of $0.33. The business has a fifty day moving average of $0.25 and a 200 day moving average of $0.32.
About Luye Pharma Group
Luye Pharma Group Ltd. is a China-based pharmaceutical company headquartered in Yantai, Shandong Province. Established in 1994, the company specializes in the research, development, manufacturing and marketing of a broad portfolio of medicaments and health-care products. Luye Pharma structures its operations across three main segments: innovative drugs, generic drugs and over-the-counter (OTC) health and wellness products. Through in-house R&D and strategic collaborations, the company aims to address unmet medical needs in both domestic and international markets.
The company’s product offerings encompass key therapeutic areas such as oncology, cardiovascular disease, gastroenterology and respiratory illnesses.
See Also
- Five stocks we like better than Luye Pharma Group
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Receive News & Ratings for Luye Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luye Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
